Clesrovimab

• CAT Number: I042084
• CAS Number: 2429913-18-6
• Purity: ≥95%

Clesrovimab（Cat No.:I042084）is an investigational monoclonal antibody designed to target the spike protein of the SARS-CoV-2 virus, which causes COVID-19. It works by binding to the virus, preventing it from entering and infecting human cells. Clesrovimab is being studied for its potential to treat or prevent COVID-19 infection, particularly in individuals at high risk of severe disease. As a part of the growing portfolio of COVID-19 treatments, it represents an approach to combat the virus by neutralizing it, providing an additional therapeutic option alongside vaccines and other treatments.